|
1
|
Brenner H, Kloor M and Pox CP: Colorectal
cancer. Lancet. 383:1490–1502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hughes LAE, Simons CCJM, van den Brandt
PA, van Engeland M and Weijenberg MP: Lifestyle, Diet, and
colorectal cancer risk according to (Epi)genetic instability:
Current evidence and future directions of molecular pathological
epidemiology. Curr Colorectal Cancer Rep. 13:455–469. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, DeSantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gòmez-Lomelí P, Bravo-Cuellar A,
Hernández-Flores G, Jave-Suárez LF, Aguilar-Lemarroy A, Lerma-Díaz
JM, Domínguez-Rodríguez JR, Sánchez-Reyes K and Ortiz-Lazareno PC:
Increase of IFN-γ and TNF-α production in CD107a+NK-92 cells
co-cultured with cervical cancer cell lines pre-treated with the
HO-1 inhibitor. Cancer Cell Int. 14:1002014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim TD, Lee SU, Yun S, Sun HN, Lee SH, Kim
JW, Kim HM, Park SK, Lee CW, Yoon SR, et al: Human microRNA-27a*
targets Prf1 and GzmB expression to regulate NK-cell cytotoxicity.
Blood. 118:5476–5486. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gong J, Maki G and Klingemann H:
Characterization of a human cell line (NK-92) with phenotypical and
functional characteristics of activated natural killer cells.
Leukemia. 8:652–658. 1994.PubMed/NCBI
|
|
7
|
Wang R, Jaw JJ, Stutzman NC, Zou Z and Sun
PD: Natural killer cell-produced IFN-γ and TNF-α induce target cell
cytolysis through up-regulation of ICAM-1. J Leukocyte Biol.
91:299–309. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schroder K, Hertzog PJ, Ravasi T and Hume
DA: Interferon-gamma: An overview of signals, mechanisms and
functions. J Leukoc Biol. 75:163–189. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Razaghi A, Owens L and Heimann K: Review
of the recombinant human interferon gamma as an immunotherapeutic:
Impacts of production platforms and glycosylation. J Biotechnol.
240:48–60. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin WW and Karin M: A cytokine-mediated
link between innate immunity, inflammation, and cancer. J Clin
Invest. 117:1175–1183. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Uemura A, Takehara T, Miyagi T, Suzuki T,
Tatsumi T, Ohkawa K, Kanto T, Hiramatsu N and Hayashi N: Natural
killer cell is a major producer of interferon gamma that is
critical for the IL-12-induced-tumor effect in mice. Cancer Immunol
Immunother. 59:453–463. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Van Heel DA: Interleukin 15: Its role in
intestinal inflammation. Gut. 55:444–445. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bahri R, Pateras IS, D'Orlando O,
Goyeneche-Patino DA, Campbell M, Polansky JK, Sandig H, Papaioannou
M, Evangelou K, Foukas PG, et al: IL-15 suppresses
colitis-associated colon carcinogenesis by inducing antitumor
immunity. Oncoimmunology. 4:e10027212015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tam YK, Miyagawa B, Ho VC and Klingemann
HG: Immunotherapy of malignant melanoma in a SCID mouse model using
the highly cytotoxic natural killer cell line NK-92. J Hematother.
8:281–290. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu LJ, Ma Q, Zhu J, Li J, Xue BX, Gao J,
Sun CY, Zang YC, Zhou YB, Yang DR and Shan YX: Combined inhibition
of JAK1,2/Stat3-PD-L1 signaling pathway suppresses the immune
escape of castration-resistant prostate cancer to NK cells in
hypoxia. Mol Med Rep. 17:8111–8120. 2018.PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Doherty TM, Seder RA and Sher A: Induction
and regulation of IL-15 expression in murine macrophages. J
Immunol. 156:735–741. 1996.PubMed/NCBI
|
|
18
|
Kobayashi H, Dubois S, Sato N, Sabzevari
H, Sakai Y, Waldmann TA and Tagaya Y: Role of trans-cellular IL-15
presentation in the activation of NK cell-mediated killing, which
leads to enhanced tumor immunosurveillance. Blood. 105:721–727.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang M, Yao Z, Dubois S, Ju W, Müller JR
and Waldmann TA: Interleukin-15 combined with an anti-CD40 antibody
provides enhanced therapeutic efficacy for murine models of colon
cancer. ProcNatl Acad Sci USA. 106:7513–7518. 2009. View Article : Google Scholar
|
|
20
|
Yu P, Steel J, Zhang M, Morris J and
Waldmann T: Simultaneous blockade of multiple immune system
inhibitory checkpoints enhances anti-tumor activity mediated by
interleukin-15 in a murine metastatic colon carcinoma model. Clin
Cancer Res. 16:6019–6028. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jakobisiak M, Golab J and Lasek W:
Interleukin 15 as a promising candidate for tumor immunotherapy.
Cytokine Growth Factor Rev. 22:99–108. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qi Z, Nie P, Secombes CJ and Zou J:
Intron-containing type I and type III IFN coexist in amphibians:
Refuting the concept that a retroposition event gave rise to type I
IFNs. J Immunol. 184:5038–5046. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takaoka A and Yanai H: Interferon
signalling network in innate defence. Cell Microbiol. 8:907–922.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Borden EC, Sen GC, Uze G, Silverman RH,
Ransohoff RM, Foster GR and Stark GR: Interferons at age 50: Past,
current and future impact on biomedicine. Nat Rev Drug Discov.
6:975–990. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Danial NN and Korsmeyer SJ: Cell death:
Critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Crisafulli S, Pandya Y, Moolchan K and
Lavoie T: Interferon gamma: Activity and ELISA detection
comparisons. Biotechniques. 45:101–102. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li P, Du Q, Cao Z, Guo Z, Evankovich J,
Yan W, Chang Y, Shao L, Stolz DB, Tsung A and Geller DA:
Interferon-gamma induces autophagy with growth inhibition and cell
death in human hepatocellular carcinoma (HCC) cells through
interferon-regulatory factor-1 (IRF-1). Cancer Lett. 314:213–222.
2012. View Article : Google Scholar : PubMed/NCBI
|
